(NASDAQ: FBIO) Fortress Biotech's forecast annual revenue growth rate of 17.39% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 11.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 18.69%.
Fortress Biotech's revenue in 2026 is $68,466,000.On average, 4 Wall Street analysts forecast FBIO's revenue for 2026 to be $2,680,419,307, with the lowest FBIO revenue forecast at $2,575,296,977, and the highest FBIO revenue forecast at $2,759,261,055.
In 2027, FBIO is forecast to generate $3,852,706,711 in revenue, with the lowest revenue forecast at $3,701,626,713 and the highest revenue forecast at $3,965,766,578.